Literature DB >> 2407431

Development of BCG as a recombinant vaccine vehicle.

W R Jacobs1, S B Snapper, L Lugosi, B R Bloom.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2407431     DOI： 10.1007/978-3-642-74983-4_11

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  18 in total

1.  Establishment of a foreign antigen secretion system in mycobacteria.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; K Terasaka; M Totsuka; K Kobayashi; H Yukitake; T Yamada
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model.

Authors:  R Janssen; A Kruisselbrink; L Hoogteijling; J R Lamb; D B Young; J E Thole
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

3.  Multidrug resistance following expression of the Escherichia coli marA gene in Mycobacterium smegmatis.

Authors:  P F McDermott; D G White; I Podglajen; M N Alekshun; S B Levy
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

4.  Molecular cloning and sequencing of the circumsporozoite protein gene from Plasmodium falciparum strain FCC-1/HN and expression of the gene in Mycobacteria.

Authors:  C Zheng; P Xie; Y Chen
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica.

Authors:  E I Igwe; H Rüssmann; A Roggenkamp; A Noll; I B Autenrieth; J Heesemann
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Authors:  S Langermann; S R Palaszynski; J E Burlein; S Koenig; M S Hanson; D E Briles; C K Stover
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

7.  Systemic and mucosal immune responses after intranasal administration of recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing glutathione S-transferase from Schistosoma haematobium.

Authors:  L Kremer; L Dupré; G Riveau; A Capron; C Locht
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Enhanced mucosal delivery of antigen with cell wall mutants of lactic acid bacteria.

Authors:  Corinne Grangette; Heide Müller-Alouf; Pascal Hols; Denise Goudercourt; Jean Delcour; Mireille Turneer; Annick Mercenier
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  The RipA and RipB Peptidoglycan Endopeptidases Are Individually Nonessential to Mycobacterium smegmatis.

Authors:  Daniel J Martinelli; Martin S Pavelka
Journal:  J Bacteriol       Date:  2016-04-14       Impact factor: 3.490

10.  Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.

Authors:  N D Connell; E Medina-Acosta; W R McMaster; B R Bloom; D G Russell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.